Monitoring patients taking methotrexate for hepatotoxicity: Does the standard of care match published guidelines?

Journal of the American Academy of Dermatology

Volumn 31, Issue 6, 1994, Pages 969-977

  Petrazzuoli, Marco ^a   Rothe, Marti Jill ^a   Grin Jorgensen, Caron ^a   Ramsey, William H ^a   Grant Kels, Jane M ^a  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHOTREXATE;

ARTICLE; DOSE RESPONSE; GASTROENTEROLOGY; HUMAN; LIVER BIOPSY; LIVER FUNCTION TEST; LIVER TOXICITY; LONG TERM CARE; PATIENT MONITORING; PRIORITY JOURNAL; PSORIASIS; RHEUMATOID ARTHRITIS; UNITED STATES;

EID: 0028104560     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(94)70266-7     Document Type: Article

References (35)

1. Therapeutic suppression of tissue reactivity: II. effect of aminopterin in rheumatoid arthritis and psoriasis
2. Methotrexate side-effects
3. Methotrexate in rheumatoid arthritis
4. Methotrexate for psoriasis
5. Hepatic fibrosis in children with acute leukemia after therapy with folic acid antagonists
6. Methotrexate-induced chronic liver injury: guidelines for detection and prevention
7. Methotrexate in psoriasis: revised guidelines
8. Hepatotoxicity of prolonged methotrexate therapy for rheumatoid arthritis
9. The pharmacology of methotrexate
10. Liver histology in rheumatoid arthritis patients receiving long-term methotrexate therapy: a prospective study with baseline and sequential biopsy samples
11. Methotrexate-induced liver abnormalities in rheumatoid arthritis
12. Liver biopsy findings in patients with rheumatoid arthritis undergoing longterm treatment with methotrexate
13. Prospective analysis of liver biopsies before and after methotrexate therapy in rheumatoid patients
14. Detection of hepatotoxicity associated with methotrexate therapy for psoriasis
15. The role of liver biopsies in psoriatic patients receiving long-term methotrexate treatment
16. Methotrexate hepatotoxicity in psoriatic patients submitted to long-term therapy
17. Psoriasis-liver-methotrexate interactions
18. Hepatotoxicity of long-term methotrexate therapy for psoriasis
19. Liver biopsies from psoriatics related to methotrexate therapy
20. Effects of methotrexate on the liver in psoriasis
21. A Debate: Should patients with rheumatoid arthritis on methotrexate undergo liver biopsies?
22. Liver biopsies from psoriatics related to methotrexate therapy
23. Methotrexate
24. Methotrexate and histologic abnormalities: a meta-analysis
25. Predictive value of HLA antigen for methotrexate-induced liver damage in patients with psoriasis
26. Methotrexate-induced liver cirrhosis: a follow-up
27. Complications following percutaneous liver biopsy: a multicenter retrospective study on 68,276 biopsies
28. Liver biopsies in patients with rheumatoid arthritis receiving methotrexate: Where are we going?
29. Long-term methotrexate therapy for rheumatoid arthritis
30. The N-terminal propeptide of collagen type III in serum reflects activity and degree of fibrosis in patients with chronic liver disease
31. Serum amino terminal propeptide of type III procollagen in psoriasis and psoriatic arthritis: relation to liver fibrosis and arthritis
32. Comparison of serum procollagen III peptide concentrations and PGA index for assessment of hepatic fibrosis
33. Dynamic hepatic scintigraphy in the screening of patients for methotrexate-induced hepatotoxicity
34. Liver biopsy versus ultrasound in methotrexate-treated psoriasis: a decision analysis
35. MTX pneumonitis in rheumatoid arthritis: a dramatic response to therapy [Letter]